Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank.
Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank.
复制标题
在英国生物库中,与不确定潜力的克隆造血相关的感染风险部分是由血液癌转化介导的。
DOI:
10.1038/s41375-023-02023-7
复制
发表时间:
2023
期刊:
影响因子:
11.4
通讯作者:
Bick,AlexanderG
中科院分区:
文献类型:
--
作者:
Vlasschaert,Caitlyn;Akwo,Elvis;Robinson-Cohen,Cassianne;Cook,ElinaK;Lanktree,MatthewB;Rauh,MichaelJ;Bick,AlexanderG
Clonal hematopoiesis of indeterminate potential (CHIP) is a recently described condition wherein a sizeable proportion of an individualLs circulating blood cells are derived from a single mutated hematopoietic stem cell [1]. The development of CHIP is a common consequence of aging: more than 10% of individuals over age 65 are affected. While CHIP is a precursor state for myeloid lineage hematologic cancers, malignant transformation is a rare event: only 0.03-1% of CHIP cases transform to cancer per year [2]. Importantly, CHIP has been associated with an increased risk of premature death and a greater burden of chronic disease across organ systems [3-8]. A central mechanism for this panchronic disease risk is the upregulation of pro-inflammatory signaling by CHIP-affected white blood cells, particularly monocytes and macrophages [3, 7-10]. There is a comparative paucity of published studies on the role of CHIP in infection risk and on the potential effects of CHIP on the function of white blood cells important in infection such as neutrophils; the literature to date is mostly limited to epidemiologic studies assessing the role of CHIP in COVID-19 and HIV infections [11-13]. A related but distinct clonal blood state, clonal mosaic chromosomal alterations, has been associated with an increased risk for diverse types of infection [14].In this work, we assess the association between CHIP and infection risk. We use data from a large observational cohort study, the UK Biobank (UKB), to determine the association between CHIP status at enrollment with incident sepsis, bacterial, and viral infections over a 12-year period. The UKB is a large observational cohort comprised of over 500,000 individuals residing in the United Kingdom who were enrolled between 2006 and 2010. Demographic data, including age, sex, and health habits, were collected at baseline, and clinical outcome data are collected on an ongoing basis from electronic health records (hospital and general practitioner records), cancer registries, and death registries. A median of 12.4 years [interquartile range, 11.6-13.1] of